Form 4 for MRNA Moderna
Accepted 2025-05-29 00:00:00 ET · period of report 2025-05-27 · accession 0001127602-25-015908 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-29 | 2025-05-27+ | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,101 | 26.3K | +4% | — |
| DM | 2025-05-29 | 2025-05-27+ | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $26.41 | -533 | 26.0K | -2% | -$14.1K |
| DM | 2025-05-29 | 2025-05-27+ | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | -1,101 | 2,302 | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-27 | M | A | 773 | — | 26,385 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2025-05-28 | F | D | 159 | $26.76 | 26,180 | D | — | — | |
| 3 | Common | Common Stock | 2025-05-27 | F | D | 374 | $26.26 | 26,011 | D | — | — | |
| 4 | Common | Common Stock | 2025-05-28 | M | A | 328 | — | 26,339 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 5 | Derivative | Restricted Stock Units | 2025-05-27 | M | D | 773 | $0.00 | 8,510 | D | — · — to — | 773 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 6 | Derivative | Restricted Stock Units | 2025-05-28 | M | D | 328 | $0.00 | 2,302 | D | — · — to — | 328 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |